BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 216 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $165,888,000 | +6.2% | 1,097,362 | +2.4% | 0.02% | +8.7% |
| Q2 2022 | $156,219,000 | +31.1% | 1,072,125 | +6.7% | 0.02% | +53.3% |
| Q1 2022 | $119,116,000 | -10.1% | 1,004,613 | +4.5% | 0.02% | -6.2% |
| Q4 2021 | $132,447,000 | +1.5% | 961,090 | +2.4% | 0.02% | -11.1% |
| Q3 2021 | $130,432,000 | +47.1% | 938,974 | +2.8% | 0.02% | +50.0% |
| Q2 2021 | $88,677,000 | +58.9% | 913,450 | +11.9% | 0.01% | +33.3% |
| Q1 2021 | $55,810,000 | -11.6% | 816,539 | +10.9% | 0.01% | -18.2% |
| Q4 2020 | $63,133,000 | +40.2% | 736,596 | +6.3% | 0.01% | +22.2% |
| Q3 2020 | $45,033,000 | -6.2% | 692,710 | +5.5% | 0.01% | -10.0% |
| Q2 2020 | $47,999,000 | +132.5% | 656,536 | +8.2% | 0.01% | +100.0% |
| Q1 2020 | $20,645,000 | -63.4% | 606,691 | -41.4% | 0.01% | -16.7% |
| Q4 2019 | $56,378,000 | +161.1% | 1,035,630 | +100.1% | 0.01% | +20.0% |
| Q3 2019 | $21,595,000 | +4.0% | 517,620 | +9.2% | 0.01% | 0.0% |
| Q2 2019 | $20,760,000 | +2.5% | 474,100 | +20.5% | 0.01% | 0.0% |
| Q1 2019 | $20,257,000 | -22.5% | 393,586 | -44.4% | 0.01% | +25.0% |
| Q4 2018 | $26,154,000 | +157.3% | 707,294 | +161.3% | 0.00% | +33.3% |
| Q3 2018 | $10,164,000 | +1.6% | 270,687 | +7.0% | 0.00% | 0.0% |
| Q2 2018 | $10,001,000 | +118.8% | 253,062 | +42.6% | 0.00% | +200.0% |
| Q1 2018 | $4,571,000 | -1.6% | 177,458 | +3.1% | 0.00% | -50.0% |
| Q4 2017 | $4,643,000 | -17.8% | 172,108 | +13.8% | 0.00% | 0.0% |
| Q3 2017 | $5,651,000 | +37.1% | 151,200 | -8.3% | 0.00% | 0.0% |
| Q2 2017 | $4,122,000 | – | 164,904 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |